Data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows that Medicaid reimbursements for services tied to COVID-19 HCPCS codes in South Lake Tahoe amounted to no less than $4,551 in 2024.
Medicaid, which is managed by states and jointly financed by federal and state governments, serves low-income residents, families, older adults, children, and individuals with disabilities, making it a major component of American health care. Read more at the Commonwealth Fund.
Because Medicaid is taxpayer-funded, variations in billing highlight how public dollars for health care are distributed locally.
This analysis defines COVID-19–related care by using only those HCPCS codes clearly marked or identified as “COVID-19” or “coronavirus” within billing data or associated references. As such, these numbers capture only directly labeled COVID-related procedures and may exclude other types of pandemic-associated claims under broader or generic codes.
For context, Medicaid payments associated with COVID-19 in San Jose were the highest in California for 2024, with reported claims reaching $5,601,479.
Barton Healthcare System was identified as the sole provider in South Lake Tahoe submitting Medicaid claims for COVID-19–related services that year.
COVID-19–specific billing led a significant rise in Medicaid spending in South Lake Tahoe during the peak pandemic period.
The Centers for Medicare & Medicaid Services report that state and federal spending for Medicaid combined reached approximately $871.7 billion for fiscal 2023—roughly 18% of all health expenditures nationwide and a substantial increase from $613.5 billion in 2019, pre-pandemic.
This uptick marks about 40% growth within a few years, as expanded coverage and increased usage surged around and following the pandemic years.
Federal budget actions under the Trump administration recently featured major efforts to trim Medicaid funding and change its framework. Notably, the “One Big Beautiful Bill Act,” enacted in 2025, is expected to significantly reduce the federal Medicaid budget by over $1 trillion during the next 10 years and implements requirements such as work mandates and higher cost-sharing, potentially affecting eligibility and funding for some recipients. These measures could increase financial responsibility for states and slow future growth of federal Medicaid allocations, with the program still serving tens of millions nationwide.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $4,551 | -82.6% | $4,994,261 |
| 2023 | $26,092 | -78.8% | $6,067,828 |
| 2022 | $123,253 | -15.8% | $5,719,669 |
| 2021 | $146,349 | 66.3% | $5,775,607 |
| 2020 | $88,017 | N/A | $5,736,910 |
| 2019 | $0 | N/A | $5,263,949 |
| 2018 | $0 | N/A | $6,700,462 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $4,551 | 247 |
Note: Amounts include only HCPCS codes specifically designated for COVID-19; they do not account for all health expenses linked to the pandemic.
Data for this report was sourced from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original datasets are available here.
